Companies
SoundFocus is a San Francisco, CA-based startup creating the next generation of personalized mobile audio products. The company was founded by Alex Selig and Varun Srinivasan in September of 2012 with the mission of helping the world hear better. The company is a graduate of the Y Combinator summer of 2013 batch and announced their first hardware product, the Amp case, in October 2014. Investors include Kapor Capital, Y Combinator, VegasTechFund, OVO Fund, RTA Capital and August Capital Partners of Singapore. Hear more at www.ampaudio.com.
Vision Disease cause innumerable cases of preventable blindness globally - 415 million diabetic patients worldwide are susceptible to Diabetic Retinopathy (DR), Glaucoma, and more. Current screening protocols for vision disease require ophthalmologists to manually diagnose patients through visual assessment of the fundus. Given the large number of diabetes patients in various communities, this process is expensive, inefficient, and an undue burden on eye clinics.
Spiral Genetics (YC W19) makes genomic data mining software to compare large populations of whole human genomes. Our customers are genetics testing companies, governments of countries, and pharma companies. We train our machine learning algorithms to enable large scale comparison of genomes to power novel discoveries, enabling new diagnostics and drugable targets.
We are a B2B medical device and data company passionate about providing remote monitoring solutions for the proactive care of chronic disease patients. Our core expertise and IP is in continuous respiratory sensing. Spire Remote Patient Monitoring is used by pulmonologists and patients throughout the United States. To date our sensors have been worn by more than 150,000 people.
Spot is building the infrastructure to support the future of at-home diagnostics. Our fully white-labeled platform helps brands offer lab-analyzed diagnostic tests using at-home collection kits. Companies simply order tests via our API, and we handle the rest—the collection kits, the logistics, physician authorization, and the lab integrations.
We are multiplying the potential of the real world by making computer vision accessible to all. We create the cloud and edge tools that developers and non-developers require in order to build, deploy, and improve CV solutions quickly. standardcyborg.com (YC W15)
Starling is building a urine diagnostic remote patient monitoring platform that seamlessly integrates into anyone's bathroom routine. By detecting early changes in a patient's urine using our toilet indwelling mass spectroscopy device, our platform is aiming to prevent hospitalizations from numerous conditions like recurrent UTIs, BPH exacerbations, or diabetes. We do this while creating significant new annual revenues for our clinician partners from remote patient monitoring reimbursements without requiring any significant changes in a staff's day to day schedule.
25 million Americans with chronic insomnia are getting inadequate and superficial care advice (e.g. cutting coffee, meditation etc.), when in reality, their sleep problems are often driven by deeper psychological challenges like unresolved anxiety. Stellar Sleep uses psychology to help these people break the insomnia cycle.
We're building an AI-enabled toolkit to keep you sober, for the 1.2 billion humans who struggle with addiction.
Addiction is one of the great problems humanity faces, there are literally billions of humans locked behind their addictions being prevented from achieving their true potential. We're building the ultimate toolkit to help keep you sober. Sunflower combines Visual Progression Tracking, an AI Sponsor, CBT-based journaling exercises, and world-class educational content. For the first time thanks to AI - technology is capable of being more powerful than a human therapist or sponsor. Our product has already helped keep tens of thousands of people sober, supporting over 3,000,000+ days of sobriety, and saving countless lives. We're going to build the worlds most effective solution to addiction, and then we're going to put it into the hands of a billion people.
Personalized virtual clinical care is finally here for neurodegenerative diseases like Alzheimer's and related Dementias (Cognitive), Parkinson's and Huntington's (Movement), and ALS (Movement). We provide a novel approach to care in these diseases, centering a patient and caregiver around a coordinator who quarterbacks patients through our full Multi-Disciplinary Care Resources to local aid, PT/OT and home health support. When you leave our clinic, it's not with a handful of paper referrals, but with our coordinators helping you book and find the best physicians, DME, trials, and even cheapest prescriptions. We are devoted to helping patients, from guidance on care and insurance to providing the full spectrum of investigational and clinical testing to improve outcomes. Synapticure was built by leading patient and caregiver advocates alongside leading clinicians, biotech executives and telemedicine executives to bring the neurodegenerative disease care and treatment experience into the 21st century, and is backed by the leading Venture funds and Angel investors in the remote health and life sciences space.
SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.
Syrona Health’s innovative insurance rider is designed to address the critical gaps in women’s health coverage by integrating fertility, menopause, and female-specific cancer care into term and life insurance for employers. Our solution directly tackles the escalating $30B in out-of-pocket healthcare costs by offering financial protection for treatments often excluded or poorly covered by traditional health insurance.
The TAXA platform has been specifically designed to enable anyone to perform metabolic engineering of plants without stepping into a lab. We provide access to protein engineering, DNA assembly, transient experiments and stable transformation as a service. The best thing is that anything "Powered by TAXA" is designed to be free from expensive regulatory approval, meaning the products are available for sale or distribution to consumers in the United States immediately after they are developed. For a detailed list of the experiments which can be run on our platform please see the Services page. Our vision is a world where bio-engineering is as easy and commonplace as mobile application development is today. Game-changing technologies, like genetic engineering, should not be the exclusive preserve of large corporations and a wealthy elite. Democratizing the tools of creation enables anyone, anywhere, to genetically engineer plants and will unleash a wave of creativity to power an environment where ultimately what we create is limited only by our imagination. The TAXA platform is our next step in the realization of that dream We are also the team behind the first synthetic biology crowdfunding project, raising $484k on Kickstarter to make real glowing plants: www.glowingplant.com
TRAC is a Chicago based startup that is focused on simplifying the track and field experience using innovative RFID technology, cellular data transmission, and unique application based software. Our integrated RFID timing system is the best in market for coaches and athletes in time based sports due to its precision, immediate feedback, and ease of use, thus saving time, effort, and money.
TYBR is developing a hydrogel to limit internal scarring after surgery. The naturally derived material is applied to coat tendons at the end of surgery to improve healing outcomes for the millions Americans who undergo tendon or ligament surgery each year.